Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Helminen

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
The Journal of Pathology|February 7, 2025
Comprehensive characterization of micropapillary colorectal adenocarcinomaVille K Äijälä, Jouni Härkönen, Tuomo Mantere, et al.
The Journal of Pathology|June 18, 2026
Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insightsAkseli Kehusmaa, Jouni Härkönen, Huayi Li, et al.
The Lancet. Oncology|July 8, 2026
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysisJudith S E Quik, Marieke A Vollebergh, Valesca P Retèl, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
The Journal of Pathology|February 7, 2025
Comprehensive characterization of micropapillary colorectal adenocarcinomaVille K Äijälä, Jouni Härkönen, Tuomo Mantere, et al.
The Journal of Pathology|June 18, 2026
Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insightsAkseli Kehusmaa, Jouni Härkönen, Huayi Li, et al.
The Lancet. Oncology|July 8, 2026
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysisJudith S E Quik, Marieke A Vollebergh, Valesca P Retèl, et al.
Pageof 15